ABCB5 and metastatic neoplasm: Previously, we reported [14] the expression of ABCB5 in unenriched whole blood from melanoma patients by RT-PCR and showed that ABCB5 transcripts were present in 40% of melanoma cases at all stages, particularly in those with disease recurrence (49%) and metastatic disease (52%).